HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases.

AbstractOBJECTIVE:
Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic small-vessel vasculitis characterized by asthma, hypereosinophilia and ANCA positivity in 40% of patients. Renal involvement is rare and poorly described, leading to this renal biopsy-proven based study in a large EGPA cohort.
METHODS:
We conducted a retrospective multicentre study including patients fulfilling the 1990 ACR criteria and/or the 2012 revised Chapel Hill Consensus Conference criteria for EGPA and/or the modified criteria of the MIRRA trial, with biopsy-proven nephropathy.
RESULTS:
Sixty-three patients [27 women, median age 60 years (18-83)] were included. Renal disease was present at vasculitis diagnosis in 54 patients (86%). ANCA were positive in 53 cases (84%) with anti-MPO specificity in 44 (83%). All patients had late-onset asthma. Peripheral neuropathy was present in 29 cases (46%), alveolar haemorrhage in 10 (16%). The most common renal presentation was acute renal failure (75%). Renal biopsy revealed pauci-immune necrotizing GN in 49 cases (78%). Membranous nephropathy (10%) and membranoproliferative GN (3%) were mostly observed in ANCA-negative patients. Pure acute interstitial nephritis was found in six cases (10%); important interstitial inflammation was observed in 28 (44%). All patients received steroids with adjunctive immunosuppression in 54 cases (86%). After a median follow-up of 51 months (1-296), 58 patients (92%) were alive, nine (14%) were on chronic dialysis and two (3%) had undergone kidney transplantation.
CONCLUSION:
Necrotizing pauci-immune GN is the most common renal presentation in ANCA-positive EGPA. ANCA-negative patients had frequent atypical renal presentation with other glomerulopathies such as membranous nephropathy. An important eosinophilic interstitial infiltration was observed in almost 50% of cases.
AuthorsCécile-Audrey Durel, Renato A Sinico, Vitor Teixeira, David Jayne, Xavier Belenfant, Sylvain Marchand-Adam, Gregory Pugnet, Jacques Gaultier, Thomas Le Gallou, Dimitri Titeca-Beauport, Christian Agard, Christelle Barbet, Antoine Bardy, Daniel Blockmans, Jean-Jacques Boffa, Julien Bouet, Vincent Cottin, Yoann Crabol, Christophe Deligny, Marie Essig, Pascal Godmer, Philippe Guilpain, Sandrine Hirschi-Santelmo, Cédric Rafat, Xavier Puéchal, Camille Taillé, Alexandre Karras, French Vasculitis Study Group (FVSG)
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 60 Issue 1 Pg. 359-365 (01 05 2021) ISSN: 1462-0332 [Electronic] England
PMID32856066 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].
Topics
  • Acute Kidney Injury (etiology, pathology)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Churg-Strauss Syndrome (complications, pathology)
  • Female
  • Humans
  • Kidney (pathology)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: